Serum heparan sulfate levels are elevated in endotoxemia by Hofmann-Kiefer KF, Kemming GI, Chappell D, Flondor M, Kisch-Wedel H, Hauser A, Pallivathukal S, Conzen P, Rehm M

Get full text

Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure) by Rogers, J, Jhund, P, Perez, A, Böhm, M, Cleland, J, Gullestad, L, Kjekshus, J, Van Veldhuisen, D, Wikstrand, J, Wedel, H, McMurray, J, Pocock, S

The Anglo-Scandinavian Cardiac Outcomes Trial: Blood pressure-lowering limb (ASCOT-BPLA): effects in patients with type 2 diabetes by Ostergren, J, Sever, P, Poulter, N, Dahlof, B, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, S, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, OBrien, E

Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol. by Sever, P, Dahlöf, B, Poulter, N, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, SE, McInnes, G, Mehlsen, J, Nieminen, M, O'Brien, E, Ostergren, J

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. by Sever, P, Dahlöf, B, Poulter, N, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, SE, McInnes, G, Mehlsen, J, Nieminen, M, O'Brien, E, Ostergren, J

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Ang... by Dahlöf, B, Sever, PS, Poulter, NR, Wedel, H, Beevers, DG, Caulfield, M, Collins, R, Kjeldsen, SE, Kristinsson, A, McInnes, GT, Mehlsen, J, Nieminen, M, O'Brien, E, Ostergren, J

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Car... by Sever, P, Dahlöf, B, Poulter, N, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, SE, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, O'Brien, E, Ostergren, J

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Car... by Sever, P, Dahlöf, B, Poulter, N, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, SE, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, O'Brien, E, Ostergren, J

Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). by Sever, P, Poulter, N, Dahlöf, B, Wedel, H, Collins, R, Beevers, G, Caulfield, M, Kjeldsen, SE, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, O'Brien, E, Ostergren, J

The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. by Ostergren, J, Poulter, N, Sever, P, Dahlöf, B, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, SE, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, M, O'Brien, E

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure. by Sever, P, Poulter, N, Dahlof, B, Wedel, H, Beevers, G, Caulfield, M, Collins, R, Kjeldsen, SE, Kristinsson, A, McInnes, G, Mehlsen, J, Nieminen, MS, O'Brien, E, Ostergren, J

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: An individual-patient data meta-analysis by Kotecha, D, Holmes, J, Krum, H, Altman, D, Manzano, L, Cleland, J, Lip, G, Coats, A, Andersson, B, Kirchhof, P, Von Lueder, T, Wedel, H, Rosano, G, Shibata, M, Rigby, A, Flather, MD

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. by Kotecha, D, Holmes, J, Krum, H, Altman, D, Manzano, L, Cleland, J, Lip, G, Coats, A, Andersson, B, Kirchhof, P, von Lueder, T, Wedel, H, Rosano, G, Shibata, M, Rigby, A, Flather, MD

Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis by Kotecha, D, Flather, M, Altman, D, Holmes, J, Rosano, G, Wikstrand, J, Packer, M, Coats, A, Manzano, L, Böhm, M, van Veldhuisen, D, Andersson, B, Wedel, H, von Lueder, T, Rigby, A, Hjalmarson, A, Kjekshus, J, Cleland, J

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis by Kotecha, D, Manzano, L, Krum, H, Rosano, G, Holmes, J, Altman, D, Collins, P, Packer, M, Wikstrand, J, Coats, A, Cleland, J, Kirchhof, P, von Lueder, T, Rigby, A, Andersson, B, Lip, G, van Veldhuisen, D, Shibata, M, Wedel, H, Böhm, M, Flather, MD

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials by Cleland, J, Bunting, K, Flather, M, Altman, D, Holmes, J, Coats, A, Manzano, L, McMurray, J, Ruschitzka, F, van Veldhuisen, D, von Lueder, T, Böhm, M, Andersson, B, Kjekshus, J, Packer, M, Rigby, A, Rosano, G, Wedel, H, Hjalmarson, Å, Wikstrand, J, Kotecha, D